281 related articles for article (PubMed ID: 7520517)
1. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
Khalaf W; Maina C; Byers J; Harvey W
Leuk Res; 2002 Feb; 26(2):169-77. PubMed ID: 11755467
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M
Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754
[TBL] [Abstract][Full Text] [Related]
4. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
Rosales C; Juliano R
Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
[TBL] [Abstract][Full Text] [Related]
5. Macrophage priming and activation during fibrosarcoma growth: expression of c-myb, c-myc, c-fos, and c-fms.
Alleva DG; Askew D; Burger CJ; Elgert KD
Immunol Invest; 1994 Nov; 23(6-7):457-72. PubMed ID: 7851963
[TBL] [Abstract][Full Text] [Related]
6. Suppression of c-myc and c-myb is tightly linked to terminal differentiation induced by IL6 or LIF and not growth inhibition in myeloid leukemia cells.
Hoffman-Liebermann B; Liebermann DA
Oncogene; 1991 Jun; 6(6):903-9. PubMed ID: 1906157
[TBL] [Abstract][Full Text] [Related]
7. Expression of oncogenes in human hepatoma cell lines.
Ting LP; Jeng KS; Chou CK; Su TS; Hu CP; Wong FH; Chang HK; Chang CM
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1988 Aug; 21(3):141-50. PubMed ID: 2854043
[TBL] [Abstract][Full Text] [Related]
8. Phorbol ester-mediated inhibition of growth and regulation of proto-oncogene expression in the human T cell leukemia line JURKAT.
Makover D; Cuddy M; Yum S; Bradley K; Alpers J; Sukhatme V; Reed JC
Oncogene; 1991 Mar; 6(3):455-60. PubMed ID: 2011401
[TBL] [Abstract][Full Text] [Related]
9. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7.
Orlic D; Anderson S; Biesecker LG; Sorrentino BP; Bodine DM
Proc Natl Acad Sci U S A; 1995 May; 92(10):4601-5. PubMed ID: 7538677
[TBL] [Abstract][Full Text] [Related]
10. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen.
Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP
Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859
[TBL] [Abstract][Full Text] [Related]
11. Alternative effects of RAS and RAF oncogenes on the proliferation and apoptosis of factor-dependent FDC-P1 cells.
McGlynn AP; Padua RA; Burnett AK; Darley RL
Leuk Res; 2000 Jan; 24(1):47-54. PubMed ID: 10634645
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cell proliferation: late down-regulation of c-myb preceding myelo-monocytic cell differentiation.
Yen A; Samuel V; Forbes M
J Cell Physiol; 1992 Oct; 153(1):147-56. PubMed ID: 1522128
[TBL] [Abstract][Full Text] [Related]
13. Different pattern of expression of cellular oncogenes in human non-small-cell lung cancer cell lines.
Kiefer PE; Wegmann B; Bacher M; Erbil C; Heidtmann H; Havemann K
J Cancer Res Clin Oncol; 1990; 116(1):29-37. PubMed ID: 1690210
[TBL] [Abstract][Full Text] [Related]
14. Histologic typing of non-Hodgkin's lymphomas by in situ hybridization with DNA probes of oncogenes.
Hamatani K; Yoshida K; Kondo H; Toki H; Okabe K; Motoi M; Ikeda S; Mori S; Shimaoka K; Akiyama M
Blood; 1989 Jul; 74(1):423-9. PubMed ID: 2526666
[TBL] [Abstract][Full Text] [Related]
15. c-myc and c-fos expression during interferon-alpha therapy for hairy cell leukemia.
Lehn P; Sigaux F; Grausz D; Loiseau P; Castaigne S; Degos L; Flandrin G; Dautry F
Blood; 1986 Oct; 68(4):967-70. PubMed ID: 3530350
[TBL] [Abstract][Full Text] [Related]
16. Specific expression of cellular oncogenes c-myc and c-myb in T-cell lines established from three types of bovine lymphosarcomas.
Ishiguro N; Matsui T; Shinagawa M
Am J Vet Res; 1993 Dec; 54(12):2010-4. PubMed ID: 8116930
[TBL] [Abstract][Full Text] [Related]
17. Differentiation primary response genes and proto-oncogenes as positive and negative regulators of terminal hematopoietic cell differentiation.
Liebermann DA; Hoffman B
Stem Cells; 1994 Jul; 12(4):352-69. PubMed ID: 7951003
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional and post-transcriptional regulation of c-myc, c-myb, and p53 during proliferation and differentiation of murine erythroleukemia cells treated with DFMO and DMSO.
Klinken SP; Holmes KL; Morse HC; Thorgeirsson SS
Exp Cell Res; 1988 Oct; 178(2):185-98. PubMed ID: 2458948
[TBL] [Abstract][Full Text] [Related]
19. Expression of cellular oncogenes in primary cells from human acute leukemias.
Mavilio F; Sposi NM; Petrini M; Bottero L; Marinucci M; De Rossi G; Amadori S; Mandelli F; Peschle C
Proc Natl Acad Sci U S A; 1986 Jun; 83(12):4394-8. PubMed ID: 3520570
[TBL] [Abstract][Full Text] [Related]
20. Modulation of c-myc, c-myb, c-fos, c-sis and c-fms proto-oncogene expression and of CSF-1 transcripts and protein by phorbol diester in human malignant histiocytosis DEL cell line with 5q 35 break point.
Gogusev J; Barbey S; Nezelof C
Anticancer Res; 1993; 13(4):1043-7. PubMed ID: 8352523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
